Chronic inflammatory demyelinating polyneuropathy in childhood can present acutely: A report of three cases
SK Chieng
Abstract
SK Chieng
Abstract
Three patients with chronic inflammatory demyelinating polyneuropathy (CIDP) with acute onset initially diagnosed as Guillain-Barre syndrome were presented. Case 1 had profound weakness over 8 weeks but followed a monophasic recovery course and was almost full recovery at 6 months and remained well one year later, whereas Case 2 recovered with two relapses at 4 and 5 months followed by full remission at 6 months. Case 3 had almost monthly relapses over 2 years, requiring monthly intravenous immunoglobulin and 4 courses of intravenous methylprednisolone. Despite frequent relapses, clinical evidence of areflexia and neurophysiologic evidence of chronic neuropathy, Case 3 remained strong during remission. No causes were found except Case 2 may be due to reactivated latent Epstein-Barr virus. Unlike those with subacute or indolent onset, CIDP with acute onset may represent a very distinct variant with good outcome. We believe that acute onset CIDP variant and Guillain-Barre syndrome most likely represent parts of a continuum, arbitrarily separated by their time course. The supporting arguments are presented; diagnosis and management difficulties are briefly discussed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Three patients with chronic inflammatory demyelinating polyneuropathy (CIDP) with acute onset initially diagnosed as Guillain-Barre syndrome were presented. Case 1 had profound weakness over 8 weeks but followed a monophasic recovery course and was almost full recovery at 6 months and remained well one year later, whereas Case 2 recovered with two relapses at 4 and 5 months followed by full remission at 6 months. Case 3 had almost monthly relapses over 2 years, requiring monthly intravenous immunoglobulin and 4 courses of intravenous methylprednisolone. Despite frequent relapses, clinical evidence of areflexia and neurophysiologic evidence of chronic neuropathy, Case 3 remained strong during remission. No causes were found except Case 2 may be due to reactivated latent Epstein-Barr virus. Unlike those with subacute or indolent onset, CIDP with acute onset may represent a very distinct variant with good outcome. We believe that acute onset CIDP variant and Guillain-Barre syndrome most likely represent parts of a continuum, arbitrarily separated by their time course. The supporting arguments are presented; diagnosis and management difficulties are briefly discussed.
Key concepts: Chronic inflammatory demyelinating polyneuropathy, Medicine, Guillain-Barre syndrome, Polyradiculoneuropathy, Methylprednisolone, Weakness, Pediatrics, Polyneuropathy